TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1
Abstract Background T cell immunoglobulin and mucin-domain containing-3 (TIM-3) is a cell surface molecule that was first discovered on T cells. However, recent studies revealed that it is also highly expressed in acute myeloid leukemia (AML) cells and it is related to AML progression. As, Glutamine...
Main Authors: | Hooriyeh Shapourian, Mustafa Ghanadian, Nahid Eskandari, Abolfazl Shokouhi, Gülderen Yanikkaya Demirel, Alexandr V. Bazhin, Mazdak Ganjalikhani-Hakemi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-11898-3 |
Similar Items
-
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
by: Jiaxiong Tan, et al.
Published: (2023-07-01) -
TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
by: Mahnaz Rezaei, et al.
Published: (2023-11-01) -
Identification and characterization of M6903, an antagonistic anti–TIM-3 monoclonal antibody
by: Dong Zhang, et al.
Published: (2020-01-01) -
Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome
by: JeongMin Sim, et al.
Published: (2022-02-01) -
Natural Killer Cells Induce CD8+ T Cell Dysfunction via Galectin-9/TIM-3 in Chronic Hepatitis B Virus Infection
by: Siyu Liu, et al.
Published: (2022-06-01)